Bilayer Therapeutics, Inc. — Form D
Bilayer Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-04-29. The offering totals $3.6M, of which $2.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-04-29
- Form: D
- Accession: 0001859506-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.6M
- Amount sold: $2.0M
- Remaining: $1.6M
- Investors: 2
- Date of first sale: 2021-04-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-397597
Issuer
- Name: Bilayer Therapeutics, Inc.
- CIK: 0001859506
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: ONE BROADWAY, 14TH FLOOR, CAMBRIDGE, MA, 02142
- Phone: 734-358-9015
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Carlo Traverso Giovanni | Director | Cambridge, MA |
| Carlo Giovanni Traverso | Director | Watertown, MA |
| Joshua A Korzenik | Director | Cambridge, MA |
| Huang Giovanni Yen-Chen | Director | Cambridge, MA |
| David Giovanni Zhu | Director | Cambridge, MA |
| Robert A Langer | Director | Watertown, MA |
| Thomas A Collet | Director | Ann Arbor, MI |
| Thomas A Collet | Executive Officer | Ann Arbor, MI |
Other filings by this issuer (1)
More